Travis Ellison

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

C. Fisher, M. Munger, R. Velagapudi, 2001, Intensive Care Medicine.